News Releases

All Releases
View Summary Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Form S-4 Registration Statement Declared Effective by SEC
Jun 13, 2017
PDF 17.3 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2017
May 15, 2017
PDF 23.3 KB Add to Briefcase
View Summary OncoGenex to Report First Quarter 2017 Financial Results on May 15, 2017
May 9, 2017
PDF 9.8 KB Add to Briefcase
View Summary Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Cytisine Symposium at the Annual Society for Research in Nicotine and Tobacco Conference ("SRNT")
Mar 8, 2017
PDF 18.8 KB Add to Briefcase
View Summary Achieve Life Science and OncoGenex Pharmaceuticals Announce Strategic Collaboration with the National Institutes of Health to Advance the Development of Cytisine for Smoking Cessation
Mar 1, 2017
PDF 19.4 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Year End 2016
Feb 23, 2017
PDF 24.5 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Announces Phase 2 Apatorsen Data for Two Clinical Trials Presented at the American Society of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium
Feb 21, 2017
PDF 70.0 KB Add to Briefcase
View Summary OncoGenex to Report Year End 2016 Financial Results on Feb. 23, 2017
Feb 16, 2017
PDF 9.8 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement
Jan 5, 2017
PDF 20.0 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2016
Nov 10, 2016
PDF 21.2 KB Add to Briefcase
View Summary OncoGenex to Report Third Quarter 2016 Financial Results on Nov. 10, 2016
Nov 3, 2016
PDF 9.8 KB Add to Briefcase
View Summary OncoGenex Announces Positive Survival Results from Apatorsen Phase 2 Borealis-2™ Trial in Metastatic Bladder Cancer
Oct 25, 2016
PDF 14.0 KB Add to Briefcase
View Summary OncoGenex Announces Results from the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer
Oct 13, 2016
PDF 14.8 KB Add to Briefcase
View Summary OncoGenex Announces Results from the Phase 3 AFFINITY Trial of Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer
Aug 16, 2016
PDF 16.0 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2016
Aug 4, 2016
PDF 24.2 KB Add to Briefcase
View Summary OncoGenex to Report Second Quarter 2016 Financial Results on August 4, 2016
Jul 21, 2016
PDF 10.7 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016
May 12, 2016
PDF 21.8 KB Add to Briefcase
View Summary OncoGenex to Report First Quarter 2016 Financial Results on May 12, 2016
Apr 28, 2016
PDF 10.7 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference
Apr 5, 2016
PDF 10.6 KB Add to Briefcase
View Summary OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Year End 2015
Mar 9, 2016
PDF 24.1 KB Add to Briefcase
Showing 1-20 of 388 Page: 1 2 3 4 5 ... 20  Next 20
Add to Briefcase = add release to Briefcase